Gyre Therapeutics
GYRE
GYRE
36 hedge funds and large institutions have $20.2M invested in Gyre Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 30 → 36 (+6)
0.25% more ownership
Funds ownership: 1.47% → 1.72% (+0.25%)
Holders
36
Holding in Top 10
–
Calls
$1.1M
Puts
$16K
Top Buyers
| 1 | +$1.36M | |
| 2 | +$1.14M | |
| 3 | +$778K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$550K |
| 5 |
AACP
Advantage Alpha Capital Partners
San Francisco,
California
|
+$334K |
Top Sellers
| 1 | -$220K | |
| 2 | -$166K | |
| 3 | -$128K | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$94K |
| 5 |
Bank of New York Mellon
New York
|
-$72.2K |